These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33282058)

  • 21. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Daher-Nashif S; Al-Anany R; Ali M; Erradi K; Farag E; Abdallah AM; Emara MM
    Arch Virol; 2022 Sep; 167(9):1773-1783. PubMed ID: 35723757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dilemma of herd immunity for COVID-19.
    Nejadghaderi SA; Safiri S
    J Med Virol; 2021 May; 93(5):2578-2579. PubMed ID: 33386744
    [No Abstract]   [Full Text] [Related]  

  • 25. Trends in adaptation of fifteen European countries population to SARS-CoV-2 in March-May 2020: Can Taiwanese experience be adopted?
    Sharov KS
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):679-687. PubMed ID: 32798031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine - We Should be Prepared.
    Moghnieh R; Abdallah D; Bizri AR
    Disaster Med Public Health Prep; 2022 Apr; 16(2):718-725. PubMed ID: 32907693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reported health and social consequences of the COVID-19 pandemic on vulnerable populations and implemented solutions in six West African countries: A media content analysis.
    Saalim K; Sakyi KS; Fatema-Tuz-Zohra ; Morrison E; Owusu P; Dalglish SL; Kanyangarara M
    PLoS One; 2021; 16(6):e0252890. PubMed ID: 34133438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    Kwok KO; McNeil EB; Tsoi MTF; Wei VWI; Wong SYS; Tang JWT
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34118274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e170122200309. PubMed ID: 35040409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and immunity: quo vadis?
    Miyasaka M
    Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The COVID-19 pandemic in francophone West Africa: from the first cases to responses in seven countries.
    Bonnet E; Bodson O; Le Marcis F; Faye A; Sambieni NE; Fournet F; Boyer F; Coulibaly A; Kadio K; Diongue FB; Ridde V
    BMC Public Health; 2021 Aug; 21(1):1490. PubMed ID: 34340668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID 19 mortality: Probable role of microbiome to explain disparity.
    Kumar P; Chander B
    Med Hypotheses; 2020 Nov; 144():110209. PubMed ID: 33254516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions.
    Fan G; Yang Z; Lin Q; Zhao S; Yang L; He D
    Transbound Emerg Dis; 2021 Mar; 68(2):213-215. PubMed ID: 32892500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
    Yewdell JW
    PLoS Pathog; 2021 Apr; 17(4):e1009509. PubMed ID: 33901246
    [No Abstract]   [Full Text] [Related]  

  • 35. [Coronavirus – cross-immunity, herd immunity and vaccine development].
    Munthe LA
    Tidsskr Nor Laegeforen; 2020 May; 140(7):. PubMed ID: 32378847
    [No Abstract]   [Full Text] [Related]  

  • 36. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.
    Yadegari I; Omidi M; Smith SR
    Sci Rep; 2021 Nov; 11(1):22970. PubMed ID: 34836984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.
    McMahon A; Robb NC
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21168. PubMed ID: 33052872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wildfire and COVID-19 pandemic: effect of environmental pollution PM-2.5 and carbon monoxide on the dynamics of daily cases and deaths due to SARS-COV-2 infection in San-Francisco USA.
    Meo SA; Abukhalaf AA; Alomar AA; Alessa OM
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10286-10292. PubMed ID: 33090440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Great Expectations of COVID-19 Herd Immunity.
    Giurgea LT; Morens DM
    mBio; 2022 Feb; 13(1):e0349521. PubMed ID: 35073740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Impouma B; Mboussou F; Farham B; Wolfe CM; Johnson K; Clary C; Mihigo R; Nsenga N; Talisuna A; Yoti Z; Flahault A; Keiser O; Gueye AS; Cabore J; Moeti M
    Epidemiol Infect; 2021 Nov; 149():e263. PubMed ID: 34732270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.